Virus infections in tumors pave the way for tumor-directed DC-vaccines

Effective treatment of solid cancers by tumor-directed DC-vaccines still remains a challenge in clinical oncology. For therapeutic success, knock-down of tumor-specific tolerance appears mandatory before a potent tumor-specific cytotoxic T-cell response can be triggered by DC-vaccinations. Evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Woller, Norman, Kühnel, Florian, Kubicka, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377008/
https://www.ncbi.nlm.nih.gov/pubmed/22720244
http://dx.doi.org/10.4161/onci.1.2.18099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377008/
https://www.ncbi.nlm.nih.gov/pubmed/22720244
http://dx.doi.org/10.4161/onci.1.2.18099

Ejemplares similares